According to a recent study, MYC can act as a master regulator for NE-differentiation and can dynamically shift tumor phenotype acting on the NOTCH signaling pathway from ASCL1 + NEUROD1+ (NE-high) to YAP1+ or POU2F3+ (NE-low) [75]. The gene discussed is ASCL1; the disease is neoplasm.